Aspirin Use and the Risk of Cholangiocarcinoma

Hepatology - United States
doi 10.1002/hep.28529
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Aspirin Use and Risk of Cholangiocarcinoma: External Validation With Big Data

Hepatology
MedicineHepatology
2017English

Association Between Aspirin Use and Risk of Hepatocellular Carcinoma

JAMA Oncology
Cancer ResearchOncology
2018English

Aspirin for Cholangiocarcinoma Prevention: New Targets to Shift the Dogma From Ascertained Risk to Possible Prevention

Hepatology
MedicineHepatology
2017English

Aspirin Use to Reduce the Risk of Sports-Related Cardiac Arrest in High-Risk Athletes

American Journal of Medicine
Medicine
2019English

Aspirin Use and Risk of Breast Cancer: Systematic Review and Meta-Analysis of Observational Studies

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2015English

Aspirin Use Is Associated With Lower Risk of Barrett's Esophagus in Women

Gastroenterology
HepatologyGastroenterology
2017English

Epidemiology, Risk Factors, and Pathogenesis of Cholangiocarcinoma

HPB
HepatologyGastroenterology
2008English

Aspirin Use in Rheumatoid Arthritis Patients With Increased Risk of Cardiovascular Disease

ISRN Rheumatology
2013English

Aspirin Use and Chronic Diseases

BMJ
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy